BeStock  
Stocks › Biotechnology › ERAS

Erasca ERAS

US equityMarket cap rank #2084Biotechnology
$13.61 −$0.61 (-4.29%)
Market closed · Nov 20, 8:20 pm ET · Last extended-hours $13.74 +0.96%
Open$13.13
Prev close$14.22
Day range$13.13 – $14.31
Volume11.07M
Market cap$4.78B
P/E (TTM)–
Dividend yield–

Fundamentals

Latest reported quarter: Q3, ended Sep 2026

Revenue$0.00
Operating profit-$59.52M-82.9% YoY
Net profit-$51.33M-67.7% YoY
Diluted EPS-$0.15-36.4% YoY
Free cash flow-$32.82M-27.9% YoY
Operating cash flow-$32.74M

Revenue, last 8 quarters

$0.0Dec '24$0.0Mar '25$0.0Jun '25$0.0Sep '25$0.0Dec '25$0.0Mar '26$0.0Jun '26$0.0Sep '26

Net profit, last 8 quarters

$-32.2MDec '24$-31.0MMar '25$-33.9MJun '25$-30.6MSep '25$-29.1MDec '25$-183.4MMar '26$-44.1MJun '26$-51.3MSep '26

Diluted EPS by quarter

-0.11Dec '24-0.11Mar '25-0.12Jun '25-0.11Sep '25-0.10Dec '25-0.60Mar '26-0.14Jun '26-0.15Sep '26

Free cash flow by quarter

$-24.6MDec '24$-31.6MMar '25$-26.1MJun '25$-25.7MSep '25$-21.7MDec '25$-177.4MMar '26$-27.3MJun '26$-32.8MSep '26

Annual revenue

$0.0FY20$0.0FY21$0.0FY22$0.0FY23$0.0FY24$0.0FY25

Profitability & balance sheet

Return on equity-48.7%
Return on assets-43.4%
Return on invested capital-48.3%
Current ratio14.89
Liabilities / assets8.2%
Cash & investments$643.70M
Total debt$37.81M
Net cash (debt)$605.88M

Income statement

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Operating Revenue $0.00 $0.00 $0.00 $0.00 $0.00
Operating Expense $59.52M $47.62M $37.91M $131.41M $32.60M
Selling and Admin Expenses $12.33M $11.72M $10.65M $38.55M $9.36M
-General & Admin Expense $12.33M $11.72M $10.65M $38.55M $9.36M
Research & Development $47.20M $35.90M $27.27M $92.85M $23.24M
Operating Profit -$59.52M -$47.62M -$37.91M -$131.41M -$32.60M
Net Non-Operating Interest Income (Expense) $8.26M $3.60M $4.45M $16.61M $3.57M
Non-Operating Interest Income $8.26M $3.60M $4.45M $16.61M $3.57M
Other Income (Expense) -$74,000.00 -$63,000.00 -$149.98M -$9.75M -$54,000.00
Special Income (Charges) $0.00 $0.00 -$150.00M -$9.50M $0.00
Other Non-Operating Income (Expenses) -$74,000.00 -$63,000.00 $22,000.00 -$248,000.00 -$54,000.00
Pretax Profit -$51.33M -$44.08M -$183.44M -$124.55M -$29.09M
Net Profit -$51.33M -$44.08M -$183.44M -$124.55M -$29.09M
Profit from Continuing Operations -$51.33M -$44.08M -$183.44M -$124.55M -$29.09M
Net Income to Parent Company -$51.33M -$44.08M -$183.44M -$124.55M -$29.09M
Net Income to Common Stockholders -$51.33M -$44.08M -$183.44M -$124.55M -$29.09M
Basic EPS -$0.15 -$0.14 -$0.60 -$0.44 -$0.10
Diluted EPS -$0.15 -$0.14 -$0.60 -$0.44 -$0.10
-Less:Other Special Charges – – $150.00M $9.50M $0.00

Balance sheet

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Assets $998.94M $435.05M $461.23M $396.15M $396.15M
Total Current Assets $655.19M $278.44M $253.78M $286.24M $286.24M
Cash and Cash Equivalents & Short-Term Investments $643.70M $268.74M $243.79M $276.08M $276.08M
-Cash and Cash Equivalents $118.96M $42.54M $47.26M $73.81M $73.81M
-Short Term Investments $524.74M $226.20M $196.53M $202.27M $202.27M
Other Current Assets $11.50M $9.70M $10.00M $10.16M $10.16M
Total Non-Current Assets $343.74M $156.61M $207.45M $109.92M $109.92M
Net PPE $37.99M $39.39M $40.88M $42.33M $42.33M
-Gross PPE $52.72M $53.42M $54.19M $54.99M $54.99M
-Accumulated Depreciation -$14.73M -$14.03M -$13.31M -$12.66M -$12.66M
Investments and Advances $304.12M $115.53M $164.72M $65.72M $65.72M
-Available for Sale Securities $304.12M $115.53M $164.72M $65.72M $65.72M
Other Non-Current Assets $1.63M $1.69M $1.85M $1.86M $1.86M
Total Liabilities $82.20M $73.19M $67.71M $70.98M $70.98M
Total Current Liabilities $43.99M $33.57M $26.66M $28.51M $28.51M
Payables $3.83M $2.02M $2.16M $981,000.00 $981,000.00
-Accounts Payable $3.83M $2.02M $2.16M $981,000.00 $981,000.00
Current Accrued Expenses $24.11M $18.00M $12.70M $10.39M $10.39M
Short-Term Debt and Capital Lease Obligation $5.59M $5.44M $5.25M $5.07M $5.07M
-Current Capital Lease Obligation $5.59M $5.44M $5.25M $5.07M $5.07M
Total Non-Current Liabilities $38.21M $39.61M $41.04M $42.47M $42.47M
Long Term Debt and Capital Lease Obligation $37.81M $39.27M $40.70M $42.07M $42.07M
-Long Term Capital Lease Obligation $37.81M $39.27M $40.70M $42.07M $42.07M
Other Non-Current Liabilities $392,000.00 $341,000.00 $340,000.00 $399,000.00 $399,000.00
Total Equity $916.74M $361.87M $393.53M $325.17M $325.17M
Stockholders' Equity $916.74M $361.87M $393.53M $325.17M $325.17M
Capital Stock $35,000.00 $31,000.00 $31,000.00 $28,000.00 $28,000.00
-Common Stock $35,000.00 $31,000.00 $31,000.00 $28,000.00 $28,000.00
-Preferred Stock $0.00 $0.00 $0.00 $0.00 $0.00
Additional Paid-In Capital $2.09B $1.48B $1.47B $1.22B $1.22B
Retained Earnings -$1.17B -$1.12B -$1.08B -$892.21M -$892.21M
Gains/Losses Not Affecting Retained Earnings -$4.19M -$1.25M -$699,000.00 $628,000.00 $628,000.00

Cash flow

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Operating Cash Flow -$32.74M -$27.27M -$27.38M -$95.46M -$21.71M
Net cash flow from continuing operations -$32.74M -$27.27M -$27.38M -$95.46M -$21.71M
Net Income from Continuing Operations -$51.33M -$44.08M -$183.44M -$124.55M -$29.09M
Gain/Loss from Continuing Operations $0.00 $0.00 -$47,000.00 – –
Depreciation & Depletion & Amortization $712,000.00 $716,000.00 $723,000.00 $3.11M $743,000.00
Other Non-Cash Items $0.00 $0.00 $150.00M $9.50M $0.00
Change in Working Capital $7.74M $7.02M -$2.33M -$3.33M $1.40M
-Change in Prepaid Assets -$2.28M $1.00M $175,000.00 $1.79M $2.18M
-Change in Payables and Accrued Expense $10.51M $6.47M -$2.09M -$3.26M -$378,000.00
-Change In Other Working Capital -$495,000.00 -$450,000.00 -$421,000.00 -$1.86M -$403,000.00
Net cash flow from investing -$488.34M $19.49M -$243.83M $100.43M $24.71M
Net Cash Flow from Continuing Investing Activities -$488.34M $19.49M -$243.83M $100.43M $24.71M
Net PPE Purchase and Sale -$79,000.00 -$8,000.00 -$36,000.00 -$128,000.00 -$9,000.00
Net Intangibles Purchase and Sale $0.00 $0.00 -$150.00M -$9.50M $0.00
Net Investment Purchase and Sale -$488.26M $19.50M -$93.79M $110.05M $24.72M
Financing Cash Flow $597.50M $3.06M $244.66M $1.10M $575,000.00
Net Cash Flow from Continuing Financing Activities $597.50M $3.06M $244.66M $1.10M $575,000.00
Net Common Stock Issuance $632.50M $0.00 $258.75M $0.00 $0.00
Proceeds from Stock Option Exercised $3.65M $3.36M $1.96M $1.10M $575,000.00
Net Other Financing Charges -$38.65M -$300,000.00 -$16.04M – –
Ending Cash Balance $119.37M $42.95M $47.66M $74.21M $74.21M
Net Change in Cash $76.42M -$4.71M -$26.55M $6.07M $3.58M
Beginning Cash Balance $42.95M $47.66M $74.21M $68.15M $70.64M
Free Cash Flow -$32.82M -$27.28M -$177.42M -$105.08M -$21.72M

Discussion

No comments yet — be the first to weigh in on ERAS.

Sign in to join the discussion.

Scroll to Top